Cited by 76Renin-Angiotensin System StudiesBlood Pressure and Hypertension StudiesEicosanoids and Hypertension Pharmacology

AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity

Boustany, Carine M, Brown, David R., Randall, David C., Cassis, Lisa A·2005·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

Abstract

Previous studies in our laboratory demonstrated that rats exhibiting obesity in response to a moderately high-fat (MHF) diet developed hypertension associated with activation of the local and systemic renin-angiotensin system. In this study, we examined the effect of the angiotensin type 1 (AT 1)-receptor antagonist, losartan, on blood pressure in obesity-prone (OP) and obesity-resistant (OR) rats fed a MHF diet. Using telemetry monitoring, we characterized the evolution of blood pressure elevations during the development of obesity. Male Sprague-Dawley rats were implanted with telemetry transducers for chronic monitoring of blood pressure, and baseline measurements were obtained. Rats were then switched to the MHF diet (32% kcal as fat) and were segregated into OP and OR groups at week 5. At week 9 on the MHF diet, OP rats exhibited significantly greater 24-h mean arterial blood pressure compared with OR rats (OP: 105 ± 4 mmHg, OR: 96 ± 2 mmHg; P < 0.05). Elevations in blood pressure in OP rats were manifest as an increase in systolic pressure. Administration of losartan to all rats at week 9 resulted in a reduction in blood pressure; however, losartan had the greatest effect in OP rats (percent decrease in mean arterial pressure by losartan; OP: 19 ± 4, OR: 10 ± 2%; P < 0.05). These results demonstrate that elevations in blood pressure occur subsequent to established obesity in rats fed a high-fat diet. Moreover, these results demonstrate the ability of losartan to reverse the blood pressure increase from diet-induced obesity, supporting a primary role for the renin-angiotensin system in obesity-associated hypertension.

Integrity signals

Registry

Crossref · 10.1152/ajpregu.00507.2004

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An important role for AngII in stimulating renal NaCl reabsorption and in mediating obesity hypertension is supported by studies in experimental animals demonstrating that AngII receptor blockade or ACE inhibition attenuates sodium retention, volume expansion, and increased BP in obesity.

    “An important role for AngII in stimulating renal NaCl reabsorption and in mediating obesity hypertension is supported by studies in experimental animals demonstrating that AngII receptor blockade or ACE inhibition attenuates sodium retention, volume expansion, and increased BP in obesity43,44.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Boustany, C. M., Brown, D. R., Randall, D. C., & Cassis, L. A.
Affiliations
University of Kentucky (US)
Venue
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Published
2005-07
Volume
289
Issue
1
Pages
R181-R186
ISSN
  • 0363-6119 (ISSN-L)
  • 1522-1490
OpenAlex
W2059519099
Cited by
76
References
46
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 6 · 2019: 1 · 2018: 1 · 2017: 4 · 2016: 6 · 2015: 4 · 2014: 6 · 2013: 3 · 2012: 9
FWCI
3.42
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Physiology-Regulatory, Integrative and Comparative Physiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01hl073085-13)
  • National Heart, Lung, and Blood Institute (HL-73085)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
losartan, diet-induced obesity, obesity-related hypertension, renin-angiotensin system, high-fat diet, obesity-prone rats, obesity-resistant rats, blood pressure, systolic blood pressure, mean arterial pressure
MeSH terms
Animals, Blood Pressure, Dietary Fats, Disease Susceptibility, Dose-Response Relationship, Drug, Male, Obesity, Rats, Sprague-Dawley, Losartan, Receptor, Angiotensin, Type 1, Angiotensin II Type 1 Receptor Blockers, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review